epirubicin actavis
actavis australia pty ltd - epirubicin hydrochloride -
irinotecan actavis
actavis australia pty ltd - irinotecan hydrochloride -
letrozole actavis
actavis australia pty ltd - letrozole -
oxaliplatin actavis
actavis australia pty ltd - oxaliplatin -
valaciclovir actavis
actavis australia pty ltd - valaciclovir hydrochloride monohydrate; valaciclovir (as hydrochloride monohydrate); valaciclovir hydrochloride -
topiramate actavis 15 15 mg capsule
actavis new zealand limited - topiramate 15 mg - capsule - 15 mg - arrow - topiramate is indicated in adults and children 2 years and over:- as monotherapy in patients with newly diagnosed epilepsy - for conversion to monotherapy in patients with epilepsy - as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.
topiramate actavis 25
actavis new zealand limited - topiramate 25mg - capsule - 25 mg - active: topiramate 25mg excipient: aniseed ethanol gelatin magnesium stearate opadry white 85f18378 povidone purified water saccharin sodium sugar spheres tekprint black sw-9008 titanium dioxide - arrow - topiramate is indicated in adults and children 2 years and over: - as monotherapy in patients with newly diagnosed epilepsy - for conversion to monotherapy in patients with epilepsy - as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.
topiramate actavis 50
actavis new zealand limited - topiramate 50mg - capsule - 50 mg - active: topiramate 50mg excipient: aniseed ethanol gelatin magnesium stearate opadry white 85f18378 povidone purified water saccharin sodium sugar spheres tekprint black sw-9008 titanium dioxide - arrow - topiramate is indicated in adults and children 2 years and over: - as monotherapy in patients with newly diagnosed epilepsy - for conversion to monotherapy in patients with epilepsy - as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.
ultravist 240
bayer new zealand limited - iopromide 498.72 mg/ml equivalent to 240 mg iodine - solution for infusion - 240 mg/ml - active: iopromide 498.72 mg/ml equivalent to 240 mg iodine excipient: hydrochloric acid as 10% solution sodium calcium edetate, hydrate trometamol water for injection - for intravascular use and use in body cavities. contrast enhancement in computerised tomography (ct), arteriography and venography, intravenous/intra-arterial digital subtraction angiography (dsa), intravenous urography, use for ercp, arthrography and examination of other body cavities. ultravist 240: also for intrathecal use. ultravist 370: especially for angiocardiography. ultravist 300/370: not for intrathecal use.
ultravist 300
bayer new zealand limited - iopromide 623 mg/ml equivalent to iodine 300 mg/ml - solution for infusion - 300 mg/ml - active: iopromide 623 mg/ml equivalent to iodine 300 mg/ml excipient: hydrochloric acid as 10% solution sodium calcium edetate trometamol water for injection - for intravascular use and use in body cavities. contrast enhancement in computerised tomography (ct), arteriography and venography, intravenous/intra-arterial digital subtraction angiography (dsa), intravenous urography, use for ercp, arthrography and examination of other body cavities. ultravist 240: also for intrathecal use. ultravist 370: especially for angiocardiography. ultravist 300/370: not for intrathecal use.